Specific site involvement in fixed drug eruption
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol.49, no.6, pp.1003-1007, 2003 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 49 Issue: 6
- Publication Date: 2003
- Doi Number: 10.1016/s0190-9622(03)01588-3
- Journal Name: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1003-1007
- Istanbul University Affiliated: No
Abstract
A total of 105 patients with established fixed drug eruption (FDE) by oral provocation were evaluated with regard to a drug-related site involvement. Cotrimoxazole was the leading causative agent (63.8%), followed by naproxen sodium (23.8%), dipyrone (5.7%), oxicams (4.8%) and other rare causes (1.9%). Cotrimoxazole most frequently induced lesions on genital mucosa; naproxen and oxicams on lips; and dipyrone on trunk and extremities. Isolated FDE on male genitalia (n = 16) was exclusively because of cotrimoxazole. A highly significant association could be established between naproxen and FIDE on lips (chi-square = 28.3; corrected P = .000002). As this study represents the largest series of patients with naproxen-induced FIDE, we would suggest that naproxen should be considered as an important potential cause of FDE on lips.